Activities per year
Activities
- 8 results
Search results
-
Anticoagulation and patient cooperation go hand in hand: The journey to 70 % TTR – How do we get there
Torben Bjerregaard Larsen (Lecturer)
4 Oct 2012Activity: Talks and presentations › Talks and presentations in private or public companies
-
A proactive approach to the monitoring of new drugs: PhVWP(h) - Pharmacovigilance Working Party (human)
Torben Bjerregaard Larsen (Lecturer)
26 Apr 2012Activity: Talks and presentations › Talks and presentations in private or public companies
-
Comparison of the CHADS2 and CHA2DS2VASc prediction rules for stroke in patients with atrial fibrillation
Torben Bjerregaard Larsen (Lecturer)
29 Aug 2011Activity: Talks and presentations › Talks and presentations in private or public companies
-
NOAC: Where are we going?
Torben Bjerregaard Larsen (Lecturer)
25 Sept 2015Activity: Talks and presentations › Talks and presentations in private or public companies
-
Strategies for a better outcome of the TTR and an improved patient compliance
Torben Bjerregaard Larsen (Lecturer)
4 Oct 2012Activity: Talks and presentations › Talks and presentations in private or public companies
-
Stroke Prevention and Anticoagulation
Torben Bjerregaard Larsen (Lecturer)
20 Jun 2014Activity: Talks and presentations › Talks and presentations in private or public companies
-
The Patient Who Is Elderly, Cognitively Impaired or Falling
Torben Bjerregaard Larsen (Lecturer)
20 Jun 2014Activity: Talks and presentations › Talks and presentations in private or public companies
-
To switch (from vitamin-K antagonist to NOAC) or not to switch – that's the question
Torben Bjerregaard Larsen (Lecturer)
25 Sept 2015Activity: Talks and presentations › Talks and presentations in private or public companies